Heart failure with normal ejection fraction (HFNEF): Is it worth considering?

Swiss Medical Weekly

Volumn 140, Issue 5-6, 2010, Pages 66-72

  Blanche, Coralie ^a   Fumeaux, Thierry ^a   Polikar, Ralf ^a  

^a General Hospital of Nyon   (Switzerland)

Author keywords

BNP; Diastolic dysfunction; Heart failure; HFNEF; HFPEF

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CONNECTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

AGING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIASTOLIC HEART FAILURE; DISEASE CLASSIFICATION; DYSPNEA; FATIGUE; HEART CATHETERIZATION; HEART DEATH; HEART FAILURE WITH NORMAL EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIA; LIFE EXPECTANCY; LUNG CONGESTION; MORBIDITY; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; SYSTOLIC DYSFUNCTION; TACHYCARDIA; THORAX RADIOGRAPHY; TISSUE DOPPLER IMAGING;

EID: 76649121186     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Meyer K, Murner N, Laederach-Hofmann K, Simmet A, Hess OM. Heart failure events, and case fatalities in Switzerland based on hospital statistics and cause of death statistics. Swiss Med Wkly. 2008;138(35-36):506-11.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325(5):293-302.
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-7.
4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341 (10):709-17.
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539-49.
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-442.
7. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(20):2539-50.
8. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VLRedfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251-9.
9. Aurigemma GP. Diastolic heart failure - a common and lethal condition by any name. N Engl J Med. 2006;355(3):308-10.
10. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355(3):260-9.
11. Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, et al. Clinical outcome of patients with heart failure and preserved left ventricular function. Am J Med. 2008;121(11): 997-1001.
12. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, Mc-Murray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777-81.
13. Zile MR, Baicu CFGaasch WH. Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350(19):1953-9.
14. Westermann D, Kasner M, Steendijk P, Spillmann F, Riad A, Weitmann K, et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation. 2008; 117(16):2051-60.
15. Tan YT, Wenzelburger F, Lee E, Heatlie G, Leyva F, Patel K, et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol. 2009;54(1):36-46.
16. Wachter R, Schmidt-Schweda S, Westermann D, Post H, Edelmann F, Kasner M, et al. Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart J. 2009.
17. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM, Jr., Magalski A, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073-9.
18. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. 2008;118(14):1433-41.
19. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation. 2002;105(16):1928-33.
20. Nijland F, Kamp O, Karreman AJ, van Eenige MJVisser CA. Prognostic implications of restrictive left ventricular filling in acute myocardial infarction: a serial Doppler echocardiographic study. J Am Coll Cardiol. 1997;30(7):1618-24.
21. Petrie MC, Hogg K, Caruana LMcMurray JJ. Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction? Heart. 2004;90(5):511-7.
22. Palmieri V, Innocenti F, Pini RCelentano A. Reproducibility of Doppler echocardiographic assessment of left ventricular diastolic function in multicenter setting. J Am Soc Echocardiogr. 2005;18(2):99-106.
23. Hatle L. How to diagnose diastolic heart failure a consensus statement. Eur Heart J. 2007;28(20):2421-3.
24. Agmon Y, Oh JK, McCarthy JT, Khandheria BK, Bailey KRSeward JB. Effect of volume reduction on mitral annular diastolic velocities in hemodialysis patients. Am J Cardiol. 2000;85(5):665-8, A11.
25. Ohte N, Narita H, Akita S, Kurokawa K, Hayano JKimura G. Striking effect of left ventricular high filling pressure with mitral regurgitation on mitral annular velocity during early diastole. A study using colour M-mode tissue Doppler imaging. Eur J Echocardiogr. 2002;3(1):52-8.
26. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation. 2000;102(15):1788-94.
27. Hadano Y, Murata K, Yamamoto T, Kunichika H, Matsumoto T, Akagawa E, et al. Usefulness of mitral annular velocity in predicting exercise tolerance in patients with impaired left ventricular systolic function. Am J Cardiol. 2006;97(7):1025-8.
28. Grewal J, McCully RB, Kane GC, Lam CPellikka PA. Left ventricular function and exercise capacity. JAMA. 2009;301(3): 286-94.
29. Skaluba SJLitwin SE. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation. 2004; 109(8):972-7.
30. Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BLRedfield MM. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005;45(1):87-92.
31. Dumesnil JG, Paulin C, Pibarot P, Coulombe DArsenault M. Mitral annulus velocities by Doppler tissue imaging: practical implications with regard to preload alterations, sample position, and normal values. J Am Soc Echocardiogr. 2002;15(10 Pt 2):1226-31.
32. Fraser AG. Echocardiographic epidemiology - an emerging tool for early diagnosis, studying pathophysiology, predicting prognosis, and testing treatments. Eur Heart J. 2009;30(6): 642-4.
33. Sanderson JE. Heart Failure with a normal ejection fraction. Heart. 2003;93(2):155-8.
34. Przewlocka-Kosmala M, Kosmala WMazurek W. Left ventricular circumferential function in patients with essential hypertension. J Hum Hypertens. 2006;20(9):666-71.
35. Yu CM, Lin H, Yang H, Kong SL, Zhang QLee SW. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation. 2002;105(10):1195-201.
36. Yip G, Wang M, Zhang Y, Fung JW, Ho PYSanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart. 2002;87(2):121-5.
37. Vinereanu D, Nicolaides E, Tweddel ACFraser AG. "Pure" diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail. 2005;7(5):820-8.
38. Mundigler GZehetgruber M. Tissue Doppler Imaging: Myocardial velocities and strain - Are there clinical Applications? J Clin Basic Cardiol. 2002;5(2):125-32.
39. Maciver DHTownsend M. A novel mechanism of heart failure with normal ejection fraction. Heart. 2008;94(4):446-9.
40. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113(16):1966-73.
41. Brunner-LaRocca HP, Widmer F, Trigo-Trindade P, Leventhal M, Seydoux C, Schmid JP, et al. Recommandations pratiques pour le diagnostic et la prise en charge de l'insufffisance cardiaque - 1ère partie: prise en charge ambulatoire. Forum Med Suisse. 2007;7(Suppl.39):3S-14S.
42. Vasan RSLevy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation. 2000;101(17):2118-21.
43. McKee PA, Castelli WP, McNamara PMKannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441-6.
44. Remes J, Miettinen H, Reunanen APyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991;12(3):315-21.
45. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DGStruthers AD. Echocardiography in chronic heart failure in the community. Q J Med. 1993;86(1):17-23.
46. Maisel A, Mueller C, Adams K, Jr., Anker SD, Aspromonte N, Cleland JGF, et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824-39.
47. Maisel AS, McCord J, Nowak RM, Hollander JE, Wu AH, Duc P, et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol. 2003;41(11):2010-7.
48. Tschope C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J. 2005;26(21):2277-84.
49. Pfister RSchneider CA. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Eur Heart J. 2009;30(3):382-3; author reply 3.
50. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation. 2006;114(5):397-403.
51. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski LTaylor J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338-45.
52. Massie BM, Carson PE, McMurray JJ, Komajda M, Mc Kelvie R, Zile MR, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23): 2456-67.
53. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007;369(9579):2079-87.
54. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-235.
55. Yip GW, Wang M, Wang T, Chan S, Fung JW, Yeung L, et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart. 2008;94(5):573-80.